Climb Bio, Inc. CLYM Balance Sheet Statement
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| $35.69M-59.1% | $87.23M-6.3% | $93.11M+114% | $43.59M-7.1% | ||
| $65.4M+2.7% | $63.69M+365% | $13.69M-82.9% | $79.98M-10.7% | ||
| $105.85M-31.7% | $154.87M+40.5% | $110.26M-18.0% | $134.39M-9.3% | ||
| $288K+44.7% | $199K— | —— | —— | ||
| $167.74M-22.8% | $217.19M+96.6% | $110.47M-18.2% | $134.99M-22.1% | ||
| $4.47M+181% | $1.59M-37.5% | $2.54M-38.7% | $4.15M-39.4% | ||
| $6.98M+41.6% | $4.93M+74.1% | $2.83M-53.5% | $6.1M+1.1% | ||
| $7.27M+37.0% | $5.31M+84.9% | $2.87M-54.3% | $6.28M+4.0% | ||
| $5K-28.6% | $7K+133% | $3K0.0% | $3K0.0% | ||
| -$289.73M-26.0% | -$229.88M-47.4% | -$155.98M-29.1% | -$120.86M-59.8% | ||
| $160.48M-24.3% | $211.88M+96.9% | $107.6M-16.4% | $128.72M-23.0% | ||
| $167.74M-22.8% | $217.19M+96.6% | $110.47M-18.2% | $134.99M-22.1% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Climb Bio, Inc.'s total assets?
- Climb Bio, Inc. (CLYM) holds $152.4M in total assets, down 24.1% year over year.
- How much debt does Climb Bio, Inc. have?
- Climb Bio, Inc. carries $479.0K in total debt against $148.1M of shareholders' equity, a debt-to-equity ratio of 0.00.
- How much cash does Climb Bio, Inc. have?
- Climb Bio, Inc. holds $8.4M in cash and equivalents.
- Can Climb Bio, Inc. cover its short-term obligations?
- Its current ratio is 27.86 — current assets exceed current liabilities.
- Where does Climb Bio, Inc.'s balance sheet data come from?
- Every line is extracted from Climb Bio, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.